Top Markets
#1 ADO Protocol ADO Protocol +324.24%
#2 Islamic Coin Islamic Coin +155.41%
#3 GoPlus Security GoPlus Security +59.57%
#4 Starpower Starpower +34.32%
#5 Verus Coin Verus Coin +33.01%
#6 GAIB AID GAIB AID +24.67%
#7 Casper Network Casper Network +14.40%
#8 o1.exchange o1.exchange +12.87%
#9 Status Status +12.12%
#10 Lumia Lumia +10.89%
Coin of the day
ADO Protocol ADO Protocol
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
NightHawk Biosciences, Inc. NightHawk Biosciences, Inc.

NightHawk Biosciences, Inc.

NHWK
Classifica tra le azioni #33280
NightHawk Biosciences, Inc. operates as an integrated biopharmaceutical firm,... NightHawk Biosciences, Inc. operates as an integrated biopharmaceutical firm, dedicated to advancing immune therapies and vaccines. Their core mission involves leveraging and modifying the body's immune system to combat a range of illnesses, particularly various cancers and infectious diseases. Central to their strategy is the proprietary gp96 platform. This platform encompasses two key technologies: ImPACT, an allogeneic (off-the-shelf) cell-based system designed to activate and expand T-cells, acting as a broad immune stimulant; and ComPACT, which combines antigen-specific T-cell activation with targeted co-stimulation in a single product. NightHawk's clinical pipeline features several promising candidates: HS-110, which has completed enrollment for its Phase II clinical trial, targeting advanced non-small cell lung cancer; and HS-130, currently undergoing a Phase I clinical trial for advanced solid tumors. Additionally, PTX-35, a novel T-cell co-stimulator agonist antibody that specifically targets DR3/TNFRSF25, is also in Phase I development. The company is also exploring DR3/TNFRSF25 as a general target for various immunotherapy applications. Beyond these, a COVID-19 vaccine is currently in preclinical stages. A notable collaboration involves Dr. James Shapiro at the University of Alberta, focusing on the manufacturing of a surrogate mouse version of PTX-35. Originally established as Heat Biologics, Inc. in 2008, the company rebranded to NightHawk Biosciences, Inc. in May 2022. Its headquarters are located in Morrisville, North Carolina.
Prezzo delle azioni
$0.3136
Ultima sincronizzazione: 2024-03-04
Capitalizzazione di mercato
$7.97M
Variazione (1 giorno)
-3.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia NightHawk Biosciences, Inc. (NHWK)

Categoria

Healthcare
Numero di azioni in circolazione per NightHawk Biosciences, Inc. (NHWK)
Numero di azioni in circolazione al August 2026: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di NightHawk Biosciences, Inc., il numero attuale di azioni in circolazione è 0. Alla fine del August 2026, la società aveva 0 azioni in circolazione. Il numero di azioni in circolazione è solitamente influenzato da split azionari e riacquisti.
Storico delle azioni in circolazione di NightHawk Biosciences, Inc. (NHWK) dal 2026 al 2026
Azioni in circolazione alla fine di ogni anno
Anno Azioni in circolazione Cambia
Non abbastanza dati per le date fornite.
Azioni in circolazione per aziende simili o concorrenti
Azienda Azioni in circolazione Differenza Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -
BE